Following the initial confirmation that the active components of Hairyvein Agrimonia had a sound docking basis with the gastric cancer target protein PTGS2, we further carried out in vitro validation experiments using gastric cancer cells. The gene discussed is PTGS2; the disease is gastric cancer.